Delivery Order SPE2DB25D3017-SPE2DB26FVGTU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, with a ceiling value of $1,135.11. This firm fixed price delivery order, which carries an ultimate completion date of September 9, 2025, represents a small-value transaction within the pharmaceutical supply chain. The award is non-set-aside and competitively awarded, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $18,082.21. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The contract is set to be completed by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,043.61 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order, awarded on October 23, 2025, with no set-aside designation, represents a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, valued at $10,380.32 under a firm fixed price contract. The award was issued on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation and was competitively awarded through the federal...
- The Defense Logistics Agency awarded a $4,803.48 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's established capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $4,540.44 with firm fixed pricing. This competitively awarded, non-set-aside delivery order is expected to be completed by September 24, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a routine pharmaceutical procurement under the company's larger federal...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors, with a contract ceiling value of $2,270.22. The award was made on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors valued at $2,902.67, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors, valued at $32,847.74. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply chain requirements. The contract carries no set-aside designation, indicating it was competitively awarded through open competition....
- The Defense Logistics Agency awarded a $5,536.88 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors under a firm fixed price contract. The award was made on September 26, 2025, with an ultimate completion date of September 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, demonstrating AmerisourceBergen's continued capability to meet federal...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB26FVGTUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors, with a ceiling value of $13,037.38. This firm fixed-price delivery order is scheduled for completion by October 27, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the contractor to supply an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. Repatha, a cardiovascular medication, falls within the company's broad therapeutic domain coverage under this strategic contract vehicle that consolidates federal medical supply needs across multiple therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 10/24/25 |